Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1999 2
2000 1
2003 1
2006 1
2008 1
2009 1
2010 1
2012 2
2013 3
2014 6
2015 3
2016 5
2017 5
2018 6
2019 5
2020 4
2021 5
2022 9
2023 15
2024 4
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council.
Choon SE, van de Kerkhof P, Gudjonsson JE, de la Cruz C, Barker J, Morita A, Romiti R, Affandi AM, Asawanonda P, Burden AD, Gonzalez C, Marrakchi S, Mowla MR, Okubo Y, Oon HH, Terui T, Tsai TF, Callis-Duffin K, Fujita H, Jo SJ, Merola J, Mrowietz U, Puig L, Thaçi D, Velásquez M, Augustin M, El Sayed M, Navarini AA, Pink A, Prinz J, Turki H, Magalhães R, Capon F, Bachelez H; IPC Pustular Psoriasis Working Group. Choon SE, et al. JAMA Dermatol. 2024 Jul 1;160(7):758-768. doi: 10.1001/jamadermatol.2024.0915. JAMA Dermatol. 2024. PMID: 38691347
Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial.
Morita A, Strober B, Burden AD, Choon SE, Anadkat MJ, Marrakchi S, Tsai TF, Gordon KB, Thaçi D, Zheng M, Hu N, Haeufel T, Thoma C, Lebwohl MG. Morita A, et al. Among authors: choon se. Lancet. 2023 Oct 28;402(10412):1541-1551. doi: 10.1016/S0140-6736(23)01378-8. Epub 2023 Sep 19. Lancet. 2023. PMID: 37738999 Clinical Trial.
Trial of Spesolimab for Generalized Pustular Psoriasis.
Bachelez H, Choon SE, Marrakchi S, Burden AD, Tsai TF, Morita A, Navarini AA, Zheng M, Xu J, Turki H, Anadkat MJ, Rajeswari S, Hua H, Vulcu SD, Hall D, Tetzlaff K, Thoma C, Lebwohl MG; Effisayil 1 Trial Investigators. Bachelez H, et al. Among authors: choon se. N Engl J Med. 2021 Dec 23;385(26):2431-2440. doi: 10.1056/NEJMoa2111563. N Engl J Med. 2021. PMID: 34936739 Free article. Clinical Trial.
Asia-Pacific consensus recommendations on the management of generalized pustular psoriasis.
Choon SE, Foley PA, Asawanonda P, Fujita H, Jo SJ, Shi YL, Theng C, Affandi AM, Bang CH, Frez ML, Huei HY, Le Huu D, Kim TG, Morita A, Oon HH, Fernández-Peñas P, Rajatanavin N, Robinson S, Selvarajah L, Tsai TF. Choon SE, et al. J Dermatol. 2024 Dec;51(12):1579-1595. doi: 10.1111/1346-8138.17471. Epub 2024 Oct 10. J Dermatol. 2024. PMID: 39390737 Free PMC article.
Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1.
Farag A, Visvanathan S, Bachelez H, Morita A, Lebwohl MG, Barker JN, Choon SE, Burden AD, Tsai TF, Leparc G, Delic D, Lang B, Thoma C, Krueger JG. Farag A, et al. Among authors: choon se. J Invest Dermatol. 2025 Mar;145(3):573-582.e8. doi: 10.1016/j.jid.2024.05.034. Epub 2024 Jul 14. J Invest Dermatol. 2025. PMID: 39004117 Clinical Trial.
Clinical Disease Measures in Generalized Pustular Psoriasis.
Burden AD, Choon SE, Gottlieb AB, Navarini AA, Warren RB. Burden AD, et al. Among authors: choon se. Am J Clin Dermatol. 2022 Jan;23(Suppl 1):39-50. doi: 10.1007/s40257-021-00653-0. Epub 2022 Jan 21. Am J Clin Dermatol. 2022. PMID: 35061231 Free PMC article. Review.
73 results